Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

8.80
Delayed Data
As of 12:57pm ET
 -0.24 / -2.65%
Today’s Change
6.17
Today|||52-Week Range
22.66
-28.97%
Year-to-Date
No recent news for Versartis Inc.

Today’s Trading

Previous close9.04
Today’s open9.25
Day’s range8.76 - 9.25
Volume10,303
Average volume (3 months)144,134
Market cap$266.0M
Dividend yield--
Data as of 12:57pm ET, 05/26/2016

Growth & Valuation

Earnings growth (last year)+35.31%
Earnings growth (this year)-14.67%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.51

Competitors

 Today’s
change
Today’s
% change
SRNESorrento Therapeutic...-0.10-1.51%
IMDZImmune Design Corp-0.28-2.11%
ARLZAralez Pharmaceutica...-0.09-2.14%
VTAEVitae Pharmaceutical...+0.02+0.21%
Data as of 1:12pm ET, 05/26/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.82
Annual revenue (last year)$0.00
Annual profit (last year)-$82.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay P. Shepard
Chief Financial Officer &
Head-Investor Relations
Joshua T. Brumm
Corporate headquarters
Menlo Park, California

Forecasts

Partner Offers

Search for Jobs